MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar

Introduction: Acromegaly (Acro) is a systemic disease characterized by high growth hormone (GH) and insulin like growth factor-I (IGF-I), insulin resistance, glucose intolerance (IGT) and higher diabetes mellitus (DM) risk in 15% - 38% of patients (pts). Moreover, different medical therapies of Acro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Endocr Soc
Glavni autori: Chiloiro, Sabrina, Giampietro, Antonella, Bianchi, Antonio, Visconti, Felicia, Formenti, Anna Maria, Cara, Fleseriu Maya, Pontecorvi, Alfredo, Fleseriu, Maria, Andrea, Giustina, De Marinis, Laura
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Neuroendocrinology and Pituitary
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208032/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.900
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items